Literature DB >> 24935335

Immunosuppressive activity of adipose tissue-derived mesenchymal stem cells in a rat model of hind limb allotransplantation.

S-H Jeong1, Y-H Ji1, E-S Yoon2.   

Abstract

Many reports have shown that bone marrow-derived mesenchymal stem cells exhibit immunosuppressive effects in allogeneic transplantation. However, few reports have evaluated the immunosuppressive properties of adipose tissue-derived mesenchymal stem cells (ASCs) in vitro and in vivo. In this study, we investigated the immunosuppressive characteristics of ASCs, and investigated whether ASCs originating from donor rats prolong allotransplant survival in a rat hind limb allotransplantation model. T-cell proliferation stimulated by allogeneic stimuli or mitogen with or without ASCs originating from the donor was assessed in vitro. The effects of cellular contact or soluble factors on the inhibition of T-cell proliferation were also evaluated. In the in vivo study, cultured ASCs (1 × 10(5)) that originated from the donor were injected into recipient animals intravenously immediately after operation, followed by 1 dose per day for 3 consecutive days post-transplantation. When immune rejection occurred, the survival time of allotransplants was determined and rejected tissue was histologically and immunochemically assessed for determining regulatory T-cell infiltration. ASCs inhibited the T-cell proliferation stimulated by alloantigen or mitogen in a dose-dependent manner, and recipient T cells proliferated less in animals treated with ASCs than in controls. Although ASCs were separated from T cells, ASCs persisted to elicit a suppressive effect. ASC culture supernatants did not inhibit T-cell proliferation; however, supernatants obtained from the mixed lymphocyte reaction in the presence of ASCs suppressed T-cell proliferation. ASCs prolonged allotransplant survival time, reduced inflammatory cell infiltration, and induced regulatory T cells. In conclusion, ASCs can exhibit in vitro immunosuppressive properties and prolong allotransplant survival time in a rat hind limb composite tissue allotransplantation model, possibly through the induction of regulatory T cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24935335     DOI: 10.1016/j.transproceed.2013.12.069

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

Review 1.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

2.  Immune Tolerance of Human Dental Pulp-Derived Mesenchymal Stem Cells Mediated by CD4⁺CD25⁺FoxP3⁺ Regulatory T-Cells and Induced by TGF-β1 and IL-10.

Authors:  Jong Won Hong; Jung Hyun Lim; Chooryung J Chung; Tae Jo Kang; Tae Yeon Kim; Young Seok Kim; Tae Suk Roh; Dae Hyun Lew
Journal:  Yonsei Med J       Date:  2017-09       Impact factor: 2.759

3.  The Frequencies of Immunosuppressive Cells in Adipose Tissue Differ in Human, Non-human Primate, and Mouse Models.

Authors:  Ariane Laparra; Sabine Tricot; Mélanie Le Van; Abderaouf Damouche; Jennifer Gorwood; Bruno Vaslin; Benoit Favier; Stéphane Benoist; Raphael Ho Tsong Fang; Nathalie Bosquet; Roger Le Grand; Catherine Chapon; Olivier Lambotte; Christine Bourgeois
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

4.  Adipose-derived cellular therapies prolong graft survival in an allogenic hind limb transplantation model.

Authors:  Jingting Chen; Yinmin Wang; Haoyue Hu; Yao Xiong; Shoubao Wang; Jun Yang
Journal:  Stem Cell Res Ther       Date:  2021-01-29       Impact factor: 6.832

Review 5.  Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species.

Authors:  Adrienne Wright; Marne L Arthaud-Day; Mark L Weiss
Journal:  Front Cell Dev Biol       Date:  2021-02-16

Review 6.  Role of microRNA Shuttled in Small Extracellular Vesicles Derived From Mesenchymal Stem/Stromal Cells for Osteoarticular Disease Treatment.

Authors:  Eliana Lara-Barba; María Jesús Araya; Charlotte Nicole Hill; Felipe A Bustamante-Barrientos; Alexander Ortloff; Cynthia García; Felipe Galvez-Jiron; Carolina Pradenas; Noymar Luque-Campos; Gabriela Maita; Roberto Elizondo-Vega; Farida Djouad; Ana María Vega-Letter; Patricia Luz-Crawford
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

Review 7.  Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite Allotransplantation.

Authors:  Richard Heyes; Andrew Iarocci; Yourka Tchoukalova; David G Lott
Journal:  J Transplant       Date:  2016-10-16

8.  Adipose-Derived Mesenchymal Stem Cells Reduce Lymphocytic Infiltration in a Rabbit Model of Induced Autoimmune Dacryoadenitis.

Authors:  Xue Li; Xiaoxiao Lu; Deming Sun; Xilian Wang; Liyuan Yang; Shaozhen Zhao; Hong Nian; Ruihua Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

Review 9.  Cell therapy in vascularized composite allotransplantation.

Authors:  Madonna Rica Anggelia; Hui-Yun Cheng; Ping-Chin Lai; Yun-Huan Hsieh; Chih-Hung Lin; Cheng-Hung Lin
Journal:  Biomed J       Date:  2022-01-15       Impact factor: 7.892

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.